approval
saveTOFACITINIB CITRATE — FDA approval
community read0 votes
Sponsor: AJANTA PHARMA LTD. Form: TABLET. Route: ORAL
view source ↗Data sources
last refreshed 5mo ago
Found something off?
drug timeline · 8
- approvalXELJANZ XR (TOFACITINIB CITRATE) — FDA approvalMar 6, 2026 · 213d ago
- approvalXELJANZ (TOFACITINIB CITRATE) — FDA approvalMar 6, 2026 · 213d ago
- approvalTOFACITINIB CITRATE — FDA approvalFeb 18, 2026 · 229d ago
- approvalTOFACITINIB CITRATE — FDA approvalFeb 18, 2026 · 229d ago
- approvalTOFACITINIB CITRATE — FDA approvalFeb 18, 2026 · 229d ago
- approvalTOFACITINIB CITRATE — FDA approvalFeb 18, 2026 · 229d ago
- approvalTOFACITINIB CITRATE — FDA approvalFeb 18, 2026 · 229d ago
- approvalTOFACITINIB CITRATE — FDA approvalNov 17, 2025 · 322d ago
same company · ±60 days · 6
- approvalDAPAGLIFLOZIN: DAPAGLIFLOZIN — FDA approvalApr 6, 2026
- approvalIVERMECTIN: IVERMECTIN — FDA approvalApr 7, 2026
- approvaltofacitinib citrate ER: TOFACITINIB CITRATE — FDA approvalFeb 18, 2026
- approvaltofacitinib citrate ER: TOFACITINIB CITRATE — FDA approvalFeb 18, 2026
- approvaltofacitinib citrate ER: TOFACITINIB CITRATE — FDA approvalFeb 18, 2026
- approvaltofacitinib citrate ER: TOFACITINIB CITRATE — FDA approvalFeb 18, 2026
🐶 often sniffed alongside
top 8- tagApproval120 co-mentions · 60 sources
- drugTOFACITINIB CITRATE111 co-mentions · 60 sources
- drugXELJANZ XR111 co-mentions · 60 sources
- drugXELJANZ111 co-mentions · 60 sources
- drugtofacitinib60 co-mentions · 60 sources
- tagSmall Molecule60 co-mentions · 60 sources
- drugtofacitinib ER60 co-mentions · 60 sources
- companyAjanta Pharma Ltd7 co-mentions · 7 sources
comments(0)
5-min edit window · permanent after that